Cargando…

Altered HDL proteome predicts incident CVD in chronic kidney disease patients

Patients with chronic kidney disease (CKD) are at high risk for CVD. However, traditional lipid risk factors, including low HDL levels, cannot completely explain the increased risk. Altered HDL proteome is linked with both CVD and CKD, but the role of HDL proteins in incident CVD events in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Baohai, Mathew, Anna V., Thornock, Carissa, Pennathur, Subramaniam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566900/ https://www.ncbi.nlm.nih.gov/pubmed/34634315 http://dx.doi.org/10.1016/j.jlr.2021.100135

Ejemplares similares

Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2023)

Pulmonary surfactant protein B carried by HDL predicts incident CVD in patients with type 1 diabetes
por: Shao, Baohai, et al.
Publicado: (2022)

Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease
por: Wang, Guisong, et al.
Publicado: (2018)

Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis
por: Mathew, Anna V, et al.
Publicado: (2015)

Response to Comment on Mathew et al. Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care 2018;41:2431–2437
por: Mathew, Anna V., et al.
Publicado: (2019)

Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
por: Vyletelová, Veronika, et al.
Publicado: (2022)

Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome
por: Mathew, Anna V., et al.
Publicado: (2018)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

HDL and chronic kidney disease
por: Pavanello, Chiara, et al.
Publicado: (2023)

Deletion of bone marrow myeloperoxidase attenuates chronic kidney disease accelerated atherosclerosis
por: Mathew, Anna V., et al.
Publicado: (2020)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic kidney disease without dialysis
por: Santana, Monique F. M., et al.
Publicado: (2020)

Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity
por: Pamir, Nathalie, et al.
Publicado: (2019)

The balance of powers: Redox regulation of fibrogenic pathways in kidney injury
por: Okamura, Daryl M., et al.
Publicado: (2015)

Urinary 2-Hydroxyglutarate Enantiomers Are Markedly Elevated in a Murine Model of Type 2 Diabetic Kidney Disease
por: Baek, Judy, et al.
Publicado: (2021)

Quantifying the HDL proteome by mass spectrometry: how many proteins truly associate with HDL?
por: Marsche, Gunther
Publicado: (2018)

The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease
por: Rysz, Jacek, et al.
Publicado: (2020)

Apolipoprotein A-1 mimetic peptide 4F promotes endothelial repairing and compromises reendothelialization impaired by oxidized HDL through SR-B1
por: He, Dan, et al.
Publicado: (2017)

Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD
por: Sharma, Sushma, et al.
Publicado: (2012)

Changes in the size and electrophoretic mobility of HDL subpopulation particles in chronic kidney disease
por: Gliwińska, Anna, et al.
Publicado: (2022)

HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation
por: Zhang, Yuling, et al.
Publicado: (2019)

Distinct WBC Trajectories are Associated with the Risks of Incident CVD and All-Cause Mortality
por: Yang, Wenhao, et al.
Publicado: (2023)

HDL Proteome and Alzheimer’s Disease: Evidence of a Link
por: Marsillach, Judit, et al.
Publicado: (2020)

HDL proteome remodeling associates with COVID-19 severity
por: Souza Junior, Douglas Ricardo, et al.
Publicado: (2021)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

Dietary flavonoid intakes and CVD incidence in the Framingham Offspring Cohort
por: Jacques, Paul F., et al.
Publicado: (2015)

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients
por: Untersteller, Kathrin, et al.
Publicado: (2018)

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case–control study
por: Gourgari, Evgenia, et al.
Publicado: (2019)

Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease
por: Afshinnia, Farsad, et al.
Publicado: (2020)

Survival Regression Modeling Strategies in CVD Prediction
por: Barkhordari, Mahnaz, et al.
Publicado: (2016)

Diabetic HDL Is Dysfunctional in Stimulating Endothelial Cell Migration and Proliferation Due to Down Regulation of SR-BI Expression
por: Pan, Bing, et al.
Publicado: (2012)

Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients
por: Xia, Wenkai, et al.
Publicado: (2020)

Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome
por: Fernandez, Maria Luz, et al.
Publicado: (2016)

Urine Glycoprotein Profile Reveals Novel Markers for Chronic Kidney Disease
por: Vivekanandan-Giri, Anuradha, et al.
Publicado: (2011)

Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease
por: Konje, Vetalise C, et al.
Publicado: (2020)

Impaired Amino Acid and TCA Metabolism and Cardiovascular Autonomic Neuropathy Progression in Type 1 Diabetes
por: Mathew, Anna V., et al.
Publicado: (2019)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

Refined purification strategy for reliable proteomic profiling of HDL(2/3): Impact on proteomic complexity
por: Holzer, Michael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t2b367jpd70fedgnsk4umlpv6t